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Introduction
The amino acid sequences of a large number of membrane proteins have been made available over the last decade by the advances in recombinant DNA technology. Methods of secondary structure prediction, mostly based on identification of putative transmembrane segments and of hydrophilic exposed domains, have been developed (Engelman et al., 1986; Eisenberg et al., 1984 ; Kyte and Doolittle, 1982) . and transmembrane folding models have been proposed on this basis for many membrane proteins. Methods used to evaluate the validity of these models are mainly based on localization of amino acid residues or segments on either side of the ( J &O&CIU CJTO&U~ 1994) membrane by labeling with site-directed ligands. Among such ligands, monoclonal antibodies (MAb) constitute a powerful tool which has proven to be very dficient both in biochemical experiments and in immuno-EM experiments. However, this approach has often been controversial, mainly because of uncertainties in antibody binding specificity and of the use of antibody concentration in large excess with respect to antigen concentration. In the case of the nicotinic acetylcholine receptor ( A m ) , proposed folding models included at least four transmembrane a-helices for each of the five subunits (Finer-Moore and Stroud, 1984; Guy, 1984;  reviewed in Popot and Changeux, 1984; Claudio et al., 1983; Devillers-Thiery et al., 1983; Kosower, 1983; Noda et al., 1983) . Anti-AChR MAb have been used with success in studies concern-flicting results (Ratnam et al., 1986a,b; Young et al., 1985) and were later &proven on the basis of biochemical approaches (DiPaola et al., 1989; McCrea et al., 1987) . This contributed to criticism of the reliability of immuno-EM studies of epitope transmembrane mapping.
We have reconsidered this approach with the goal of visualizing by EM the binding of MAb to AChR-rich membrane fragments in concentration conditions predetermined by classical ELISA. We have developed a reliable method using anti-AChR MAb directed against previously identified epitopes. During this study, we found a novel approach that makes it possible to distinguish between two levels of accessibility for extracellular epitopes. The methods presented here might be of general application for studies of epitope mapping of membrane-bound antigens.
Materials and Methods
Anti-AChR W b . The production and characterization ofthe anti-AChR MAb used have been described earlier (for review see Tzartos, 1990) . MAb 35 and MAL 4 were selected as representative of MAb directed against extracellular epitopes. Both bind to the main immunogenic region (MIR), corresponding to residues 67-76 of the a-subunit (Tzartos et al., 1988) .
MAb 111 was chosen as representative of MAb directed against intracellular epitopes. as it binds to residues 368-406 of the 8-subunit (Ratnam et al., 1986a; fiartos et al., 1986; and Bartos and Valcana, unpublished ob-Preparation of AChR-contaiaing Native Membranes. AChR-rich fragments were prepared from either fresh or frozen Torpedo "norutu elecm c organ (Institut de Biologic Marine; W o n , France) according to Sobel et al. (1977) . without the purification step by centrifugation on a sucrose gradient. Membrane suspensions contained about 10% of AChR-rich membranes, as estimated by their content of a-bungarotoxin binding sites, by SDS-PAGE, and by EM. The presence of non-AChR membranes was used as an internal control for MAb binding specificity. The content in acetylcholine receptor sites was estimated using [3H]-a-bungarotoxin (Amersham; Poole, UK), either by sedimentation for membrane-bound AChR or by adsorption on DEAE filters for detergent-solubilized AChR (Saitoh and chulgeux, 1980) . Protein concentration was determined by the method of Bradford (1976) , using bovine serum albumin (BSA) as a standard.
Tubular two-dimensional (ZD) crystals of AChR were prepared as described in Brisson and Unwin (1984) .
Preparation OfChoIate-solubilized AChR. Solubilization of membranes with cholate was performed according to Sobel et al. (1980) . To 1 volume ofmembranes at 2.5 mg proteinlml in 0.1 M %is, pH 6.8, was added 1/9 volume ofcholate 31%. After a briefmixing, 2 volumes of0.l M Tris, pH 6.8, were added to bring the cholate final concentration to 1%. Nonsolubilized material was discarded by centrifugation for 30 min at 30 krpm in a Bcckman-R50 rotor. Aliquots were stored at -8O"C, as cholatesolubilized AChR is not stable at 4%.
hunents for Membrane Opening. The following treatments were assayed pH 11. saponin (between 0.01% and 0.1%), lithium diiodosalicylate (10 mM), as described by Neubig et al. (1979 ). St John et al. (1982 . and Froehner et al. (1983) . respectively. Prepmtion ofmembranes in the presence ofZn2+ ions and sucrose was performed as described in Sealock et al. (1984) , with minor modifications. Frozen elecuic organ (20 g) was thawed and homogenized at 4% in 34 ml of a buffer containing 2 mM ZnClz, 25% sucrase, 1 mM N-ethylmalehide, 2.5 pg of protease inhibitorS(1eupeptin and pepstatin)/ml, 20 mM Tris, pH 7.4, using a Wuing homogenizer servations). at full speed for 40 sec. The homogenate was centrifuged at 3 krpm for 10 min in a Sorvall-HS4 rotor. The supernatant was filtered through two layers of gauze and was centrifuged at 20 krpm for 30 min at 4% in a Beckman-R45Ti rotor. The loosely bound pellet was re-suspended in 10 ml of0.l M sodium cacodylate, pH 6.8, containing 1 mM N-ethylmaleimide, 50 BM ZnClz, and 2.5 pg of protease inhibitors/ml. After a second centrifugation step, the final pellet was re-suspended in 5 ml of the previous buffer. The resulting membrane suspension was aliquotted and stored at -8O' C until use. U S A Experiments. Special attention was given to designing similar experimental protocols for measuring the binding of MAb to AChR-rich membranes by ELISA and for visualizing this binding by immuno-EM. Owing to the aggregation of MAb at low concentrations, the binding reaction between MAb and membrane-bound AChR could not be simply evaluated by direct adsorption of MAb to microtitration wells (data not shown). An indirect assay was developed, in which the binding reaction was performed in the presence of 1% BSA to protect against MAb aggregation and unbound MAb were quantified by specific binding to wells pre-coated with cholate-solubilized AChR. Microtitration wells (Nunc; Roskilde, Denmark) were coated with cholate-solubilized AChR by incubation overnight at 4'C with 100 p1 of a solution containing 1 pg of solubilized AChR (1 volume ofa 1% cholate-solubilized AChR at 0.5 mg protein/ml was diluted with 50 volumes of 0.1 M Tiis, pH 6.8). Coating performed in the presence of either 1% cholate or 0.02% cholate gave identical results (data not shown).
After washing, the wells were saturated with 400 pl PBS-1% BSA for 2 hr at 37'C.
A given quantity (0.4-2 pmol) of MAb was incubated with a variable amount of membrane (~5 0 0 nmol a-bungarotoxin binding sitcs/g of protein) for 1 hr at room temperature (RT) in a total volume of 150 p1 PBS-1% BSA. These suspensions were directly added to AChR-coated w e h and incubated for 1 hr at RT. Elimination of membrane fragments by sedimentation before incubation provided identical results (data not shown), indicating that membrane-bound MAb did not interfere with the binding of free MAb to AChR-coated wells.
MAb were revealed by subsequent addition of alkaline phosphataseconjugated goat anti-rat IgG (Jackson Immunoresearch, Avondale, PA) and ofp-nitrophenyl phosphate disodium, followed by optical density (OD) measurement at 405 nm. Binding of MAb to 1% cholate-solubilized AChR was carried out using the same protocol.
The titers of MAb solutions were determined both by immunoprecipitation of solubilized AChR labeled with [3H]-a-bungarotoxin and by titration of a given quantity of MAb by known quantities of solubilized AChR (data not shown). Titers of stock solutions of MAb 35, 4, and 111 are 20 pM, expressed as the number of a-bungarotoxin binding sites precipitated per liter.
Complementary experiments indicated that saturation of AChR-coated wells was obtained with 0.3 pmole for each of the three MAb (4, 35, 111) (data not shown).
Elcctmn bficmm". Au EM observations were made by negative staining with 2% sodium phosphotungstate (Na-PTA), pH 7.2. Two hundred p1 of membrane solutions at 0.2 mg proteinlml were added with 40 pmol of MAb (2 pI of stock solution) and incubated for 1 hr at RT. The suspension was passed through a CL2B Sepharose gel filtration column (molecular weight cutoff40 x IO6 daltons; 8 un height; 0.7 un inner diameter).
To 150 p1 of the most membrane-rich fraction was added 6 JLI of pure goat anti-rat IgG coupled to 5-nm colloidal gold partides (BioCell; GrM, UK).
After 1 hr of incubation at RT, a second step of gel fdtration was performed.
The most membrane-rich W o n was negatively stained and observed by EM.
EM was carried out on a Philips CM12 electron microscope operating at 100 kV. No special care was taken to decrease the electron irradiation of specimens. Electron micrographs were recorded on Kodak SO163 film and developed under standard conditions.
ReSUitS

MA6 Binding to Native Membranes
The binding reaction between MAb and native membrane fragments was followed by measuring the amount of unbound MAb by ELISA, using microtitration wells pre-coated with solubilized AChR. As shown in Figure 1 , the amount of membrane required to titrate 2 pmol of MAb 35 or 4 corresponded to 2 pmol of a-bungarotoxin binding sites. The stoichiometry of the binding reaction, defined as the ratio between the number of MAb molecules and the number of AChR molecules at the titration point, both values being expressed in a-bungarotoxin binding sites, was 1.02 (a = 0.18; n = 5) for MAb 35 and 1.3 (a = 0.08; n = 4) for MAb 4. These results suggested that all MIR epitopes were accessible to corresponding MAb in native membranes. Howevet, these absolute values are only indicative, as measurements of either the titers of MAb solutions or the specific activities of membrane suspensions are subject to error. A more exact evaluation of the stoichiometry was obtained by comparing the binding of MAb to membrane-bound AChR and to 1% cholate-solubilized AChR, as all epitopes are considered accessible in solubilized AChR solutions. No difference was observed in the binding of MAb 4 to either membrane-bound AChR or solubilized AChR (Figure 2 ).
Titration of a given amount of MAb 111 by native membranes required a large excess of membrane-bound AChR in comparison with MAb 35 and 4 (Figures 1 and 2) . The amount of membrane varied with membrane batches as well as with membrane aging. A mean stoichiometric ratio of 0.14 ( 0 = 0.1; n = 5) was found for the binding reaction between MAb 111 and native membranes. On the other hand, MAb 111 was found to bind to 1% cholatesolubilized AChR as well as MAb 4 (Figure 2) . These experiments therefore indicated that native membranes presented a low and 0 m A b l l l mAb35 0 mAb4 variable amount of accessible intracellular epitopes. On average, 10% of intracellular epitopes were accessible to MAb.
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EM Vkuaiization of MAb Binding to
Native Membranes
In membrane preparations of Torpedo electric tissue, AChR-rich vesicles are easily distinguished from non-AChR vesicles by the pmence of a high density of rosette-shaped particles about 8 nm in diameter, identified as AChR molecules (Eldcfrawi et al., 1975; Cartaud et al., 1973) . Visualization of MAb binding to native membranes was performed at MAbAChR molar ratios corresponding to titration points in ELISA curves. Bound MAb were revealed by secondary antibodies coupled to 5-nm colloidal gold particles. After antibody labeling, the characteristic rosette shape of AChR molecules was still visible although less pronounced (Figure 3a ). Binding of MAb 35 was characterized by gold particles distributed over the surface of AChR-rich membrane vesicles, as well as projecting beyond the outer edge of the vesicles (Figures 32 and 3b ). More than 95% of AChR-rich vesicles exhibited this characteristic labeling. Similar labeling was also observed on AChR tubular 2D crystals (Figure 3c ), a characteristic type of membrane structure that forms spontaneously in native membrane preparations (Brisson and Unwin, 1984) the quantity of second antibody added, which was chosen to be low enough that the overall aspect of the membrane was visible. Therefore, gold particles were used here in a qualitative rather than a quantitative manner.
Binding of MAb 111 to AChR-rich membranes was markedly different. Most of the AChR-rich membrane vesicles and all tubular 2D crystals were devoid of gold particles (Figures 4a and 4b) .
Gold particles were associated either with AChR-rich vesicles displaying an altered membrane structure (Figure 4a ) or with membrane debris (Figure 4c ). Some rare AChR-rich vesicles (<5%) showed an unusual intense labeling with gold particles (data not shown). These small membranes were interpreted as inside-out AChR-rich vesicles. As mentioned previously for MAb 35 and 4, a complete absence of gold particles was noticed with MAb 111 on non-AChR vesicles (Figure 4a ).
Treatments for Membrane Opening
The following treatments, previously proposed to open sealed membranes and to render accessible their internal space, were tested: pH 11. saponin, lithium diiodosalicylate, and zinc ions (Scalock et al., 1984; Porter and Froehner, 1983; St John et a!., 1982; Neubig et al., 1979) . Treatment of membranes at pH 11 was found to dramatically alter the integrity of vesicles. The number of AChRrich vesicles labeled by MAb 111 was variable but was always <lo% b (data not shown). This variability in the extent of permeabilization by pH 11 treatment has already been reported by St John et al. (1982) . Treatment with 10 mM lithium diiodosalicylate was also rejected because it had serious dfects on the membrane structure. Treatment of membranes with saponin also caused a marked alteration ofthe membrane structure ( Figure 5 ). Membranes showed areas with densely packed hole-like structures (arrows in Figures  5a and 5 b) . These structures often had a highly homogeneous circular shape (12 nm in diameter) with intense central staining. As expected, the effect of saponin was dependent on the relative amount between saponin and lipid. After incubation for 15 min with 0.03% saponin, all vesicles in a membrane suspension containing 0.2 mg lipidlml exhibited hole-like structures. In addition, dixontinuities in the membrane structure were frequently observed along vesicle edges (arrowheads in Figures 5b and 5c ). These discontinuities were contiguous to areas showing a high density of holelike structures. Membranes of different origins were not affected similarly, and AChR-rich membranes appeared less sensitive to saponin than other membranes. MAb 35 bound to AChR-rich vesicles treated with saponin, but no binding or weak binding was observed for MAb 111 (Figure 5c ). In addition, saponin treatment induced the formation ofa large amount of membrane debris to which MAb 35 and MAb 111 bound (data not shown). Preparation of membranes in the presence of 2 mM ZnCl2 and 25% sucrose resulted in minor changes in the overall aspect of native membranes, except for the presence of characteristic openings (Figures 6 and 8) . These openings were most easily visible at the edges of vesicles ( Figures  6 and 8, arrows) . They were of variable size, up to several hundred nanometers in diameter. The proportion of AChR-rich membranes showing these characteristic openings was variable with membrane batches, ranging from 20% to 50%. Membranes homogenized in the presence of 2 mM ZnClz and 25 % sucrose were less stable than native membranes and were kept frozen until use. Complementary experiments have shown that membranes treated with Zn2+ ions in the absence of sucrose exhibited similar openings (data not shown). Therefore, this treatment will be referred to as Zn2+ treatment.
MA6 Binding to Znp-treated Membranes
The binding of MAb 35 and MAb 4 to Zn2+-treated membranes, as measured by ELISA, was similar to their binding to native membranes (Figure 7) . On the other hand, binding ofMAb 111 to Zn2+treated membranes was higher than to native membranes ( Figure  7) . The stoichiometry of the binding reaction between MAb 111 and Zn2+-treated membranes was 0.26 (a = 0.09; n = 5).
Observed by immuno-EM, binding of MAb 35 and MAb 4 to Znz+-treated membranes was similar to their binding to native membranes (Figure 8a) . Gold particles were evenly distributed over the vesicle surface, as well as projecting beyond the edge of the vesicles. Binding of MAb 111 to Zn2+-treated membranes was strik-ingly different (Figures 8b and 8c) . Gold particles were limited to the projected surface of the vesicles, and no gold partides were located beyond the outer edge of the vesicles. More than 80% of AChR-rich membranes presenting characteristic Znz+-induced openings were labeled specifically. No gold particles were observed on AChR-rich membranes devoid of characteristic openings, as well as on non-AChR membranes (Figure 8c) . Therefore, the difference in binding measured by ELISA between MAb 35 and MAb 111 is likely to result from the incomplete efficiency of the Znz+induced opening treatment.
Dhtinction Between Two Levels of Erttacelular Epitope Accessibility
During the course of this study, one antibody, MAb 14, was found to display unusual behavior, which enabled us to distinguish two levels of accessibility for extracellular epitopes. MAb 14 was previously shown by Kordossi and Tzartos (1989) to bind to an extracellular epitope; however, its sequence specificity is still unknown. Binding of MAb 14 to native membranes was similar to the binding of other MAb directed against extracellular epitopes, such as MAb 35 (Figure 9 , large arrow).
However, almost no binding of MAb 14 was observed on tubular 2D crystals (Figure 9 ). Such tubular crystals exhibit a higher packing density of AChR molecules ( Brisson and Unwin, 1984) . Binding of MAb 14 was restricted to non-crystalline areas present either at the tube extremities or at defective areas within tubular portions (Figure 9 ). This behavior is in contrast with MAb 35, which showed no difference of binding between AChR tubular 2D crystals and native membrane vesicles (Figure 3c) . These experiments indicated that the epitope associated with MAb 14 is located on the extracellular side of the membrane, on the periphery of the molecule, at a level closer to the lipid bilayer than MIR epitopes. Such a localization for the epitope of MAb 14 at the side of the AChR molecule, near the intramembranous portion of the AChR, was previously postulated by Kordossi and Tzartos (1989) on the basis of biochemical evidence.
Discussion
The present work used a combined ELISA-immuno-EM study of the localization of epitopes of the membrane-bound nicotinic AChR. An experimental protocol was developed to visualize the binding between MAb and both extracellular and intracellular epitopes of the AChR in near-equimolar concentrations. Our results strongly suggest that MAb bind to MIR epitopes in a stoichiometric manner, although an exact evaluation of the stoichiometry is difficult because of inaccuracy in the estimation of a-bungarotoxin binding sites. The fact that MAb directed against MIR epitopes bind to solubilized AChR and to membrane-bound AChR with 4 Figure 8. Immun*EM visualization of (a) MAb 35 and (b,c) MAb 11 1 binding to Zn2+ treated membranes. (a) the same stoichiometry further supports the result that all MIR epitopes are accessible to MAb on native membranes.
MAb binding to extracellular epitopes results in homogeneous coverage of sealed native membranes with gold particles, whereas no labeling is observed with MAb directed against intracellular epitopes. Distinction between intracellular and extracellular epitopes is possible because AChR-containing vesicles are sealed and exhibit a well-defined polarity (StJohn et al.. 1982; Devine-Strader et al., 1979) . This feature is frequently observed with other specialized membranes, such as CaZ+-ATF'ase-. or rhodopsin-rich membranes, brush border membranes, and mitochondrial membranes.
This study emphasizes the complementarity b e m e n immuno-EM experiments and ELISA biochemical experiments. According to ELISA, a non-negligible proportion of intracellular epitopes was accessible to MAb in native membrane preparations. This could be interpreted as resulting either from a variable proportion of inside-out vesicles or from a law-affinity binding of MAb 111 to the entire population of intracellular epitopes. Immuno-EM experiments showed unambiguously that the signal measured in ELISA corresponded to membrane debris (Figure 4c ). Such membrane debris is always present to a variable extent in membrane preparations, and should be taken into account in any quantita-tive analysis ofmembrane-bound components. This also holds true for reconstituted membranes and liposomes, which always display a variable proportion of open vesicles. Therefore, interpretation of ELISA experiments, which are often performed at antigemntibody ratios ranging over several orders of magnitude, would certainly benefit from a complementary EM study.
Immuno-EM experiments were realized by the negative staining method (for review see Home, 1965) which has already been used extensively in immuno-EM studies of membrane-bound antigens. This method has several important advantages with respect to the classical method of thin-sectioning in the case of membranous subcellular preparations: (a) it allows EM experiments to be performed in controlled concentration conditions; (b) it avoids treatments such as fixation or organic solvent dehydration, which could alter the structural integrity of epitopes; (c) in the present case it enabled the distinction to be made between AChR-rich and non-AChR membranes; (d) it allows direct evaluation of the effects of membrane permeabilization treatments on membrane structure integrity; and (e) it is fast and simple. Other methods, based on the adsorption of membrane vesicles on a solid support, are also well adapted for visualizing antibody labeling (Bridgman et al., 1987; Wray and Sealock, 1984) . However the antigen:antibody ratio at which the binding reaction is performed cannot be controlled, as the amount of membrane-bound antigen is unknown. An important advantage of negative staining is that it allows direct evaluation of permeabilization treatments, as illustrated by the treatment with saponin in this study. Saponin markedly affects membrane integrity, causing hole-like structures to form, although no binding of MAb 111 is observed on these membranes by immuno-EM. In addition, at a high saponin:lipid ratio, saponin induces the formation ofmembrane debris to which MAb 111 binds. The hole-like structures are not specific for AChR-rich membranes; they have also been observed with synthetic lipid vesicles containing cholesterol (Lucy and Glauert, 1964) . It should be noted that conflicting results have been reported on the efficiency of saponin to "open" vesicles Porter and Froehner, 1983; St John et al., 1982; Froehner, 1981) , which is likely to reflect the variable formation of membrane debris.
We show that the treatment involving Zn2+ ions and sucrose provided an appropriate way to gain access to the interior of AChR- It is important to note that with MAb such as MAb 35 or MAb 111, identical results were obtained by immuno-EM at (MAbmembrane-bound AChR) molar ratios ranging from 1 to 100 (data not shown). On the other hand, several MAb, mainly MAb presumed to be directed against "key" sequences, provided d a ring results in the distribution of gold particles, suggesting either that they recognized more than one amino acid sequence or that they did not recognize a native epitope. This study strengthens the point that MAb used for localization studies of membrane protein epitopes should fulfill stringent criteria, developed extensively by Pedersen et al. (1990) and summarized here: (a) highly purified MAb directed against sequential epitopes should be used; (b) immuno-EM and ELISA should yield concordant results; and (c) immuno-EM should be performed on the native stfllcture. We consider that two further conditions should be satisfied whenever possible. First, immuno-EM and biochemical binding experiments should be performed under similar experimental conditions. EM is particularly well adapted to visualize membrane s t r u m so that, in principle, it should be possible to visualize any binding reaction. Second, the stoichiometry of the binding reaction between MAb and both membrane-bound antigens and solubilized antigens should be determined. Stoichiometric binding is a good indication, although not a proof, that binding concerns a homogeneous population of antigens. This is particularly important when membrane opening treatments are used, because they may lead to some degree of denaturation.
The peculiar behavior observed with MAb 14 deserves some remarks. The availability of m types of membrane preparations differing in packing densities allowed us to refiie the localization ofthe corresponding epitope within the extracellular domain. Our results suggest strongly that this epitope is located at the periphery of the molecule and at a closer distance to the membrane level than MIR epitopes. This provides a simple assay for classifying all extracellular epitopes into one of two categories, one corresponding to accessible epitopes, such as the MIR, and the other corresponding to epitopes inaccessible in tubular crystalline areas, or cryptotopes. The same approach might be applied to other membrane-bound antigens, as 2D crystals have been obtained with a variety of specialized membranes, such as those containing rhodopsin, Ca2+-ATPase, NA+,K+-ATPase, or mitochondrial enzymes (Hofhaus et al., 1991; Valpuesta et al., 1990; M o b et al., 1985; Zylor et al., 1984; Corless et al., 1982) . This type of information could provide constraints useful for generating structural models ofmembrane proteins or for evaluating the validity ofmodels based on theoretical considerations. In conclusion, the method presented here is adapted for mapping all accessible epitopes of a membrane protein, provided that well-characterized MAb are available. 
